VB-1953
/ Vyome Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 15, 2020
Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects.
(PubMed, Clin Drug Investig)
- "VB-1953 topical gel appears to be safe for use in adults with facial acne vulgaris and may offer new advances as a topical antibiotic agent for the disease."
Clinical • Journal • P1 data • PK/PD data • Acne Vulgaris • Dermatology • Dermatopathology • Hematological Disorders
1 to 1
Of
1
Go to page
1